Enhanced psychophysiological signs of attention after angiotensin-converting enzyme inhibition by captopril

被引:7
作者
Derad, I
Pietrowsky, R
Dodt, C
Fehm, HL
Born, J
机构
[1] UNIV LUBECK,DEPT CLIN NEUROENDOCRINOL,W-2400 LUBECK,GERMANY
[2] UNIV LUBECK,DEPT INTERNAL MED,W-2400 LUBECK,GERMANY
关键词
angiotensin-converting enzyme inhibitor; cardiovascular activity; catecholamines; auditory event-related potentials; humans;
D O I
10.1111/j.1469-8986.1996.tb00426.x
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Complementary to its essential role in the central nervous control of cardiovascular activity, the neuropeptide angiotensin II may regulate attentional processes. The present study evaluated central nervous, cardiovascular, and sympathetic indicators of attention after inhibition of angiotensin II synthesis by captopril (50 mg vs. placebo) in 14 men. Event-related potentials (ERPs) and stimulus-related electroencephalographic (EEG) activity were recorded while the subject performed an auditory oddball task. Captopril increased both the N1-P2 component of the ERP (p <.05) and- following the first tone of the task - the EEG desynchronization in the lower alpha frequency band (p <.05). Although blood pressure remained unchanged, heart rate was lowered (p <.05) and plasma norepinephrine concentrations increased (p <.01) after captopril. The effects suggest that inhibition of angiotensin II synthesis enhances an attentional state typically present during sensory intake.
引用
收藏
页码:295 / 301
页数:7
相关论文
共 37 条
[1]   TIME COURSE OF ACTH 4-10 EFFECTS ON HUMAN ATTENTION [J].
BORN, J ;
UNSELD, U ;
PIETROWSKY, R ;
BICKEL, U ;
VOIGT, K ;
FEHM, HL .
NEUROENDOCRINOLOGY, 1990, 52 (02) :169-174
[2]   COGNITIVE FUNCTION AND ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN COMPARISON WITH OTHER ANTIHYPERTENSIVE DRUGS [J].
BULPITT, CJ ;
FLETCHER, AE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 :S100-S104
[3]  
CAPPONI AM, 1981, BIOCH REGULATION BLO, P156
[4]   THE EFFECTS OF ANTIHYPERTENSIVE THERAPY ON THE QUALITY-OF-LIFE [J].
CROOG, SH ;
LEVINE, S ;
TESTA, MA ;
BROWN, B ;
BULPITT, CJ ;
JENKINS, CD ;
KLERMAN, GL ;
WILLIAMS, GH .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (26) :1657-1664
[5]   CENTRAL EFFECTS OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, CAPTOPRIL .1. PERFORMANCE AND SUBJECTIVE ASSESSMENTS OF MOOD [J].
CURRIE, D ;
LEWIS, RV ;
MCDEVITT, DG ;
NICHOLSON, AN ;
WRIGHT, NA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (04) :527-536
[6]   COMPARISONS INVITRO, EXVIVO, AND INVIVO OF THE ACTIONS OF 7 STRUCTURALLY DIVERSE INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME (ACE) [J].
CUSHMAN, DW ;
WANG, FL ;
FUNG, WC ;
GROVER, GJ ;
HARVEY, CM ;
SCALESE, RJ ;
MITCH, SL ;
DEFORREST, JM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 :S115-S131
[7]   IS THE P300 COMPONENT A MANIFESTATION OF CONTEXT UPDATING [J].
DONCHIN, E ;
COLES, MGH .
BEHAVIORAL AND BRAIN SCIENCES, 1988, 11 (03) :357-374
[8]  
Donchin E., 1986, PSYCHOPHYSIOLOGY SYS, P702
[9]   PHARMACOKINETICS OF CAPTOPRIL IN HEALTHY-SUBJECTS AND IN PATIENTS WITH CARDIOVASCULAR-DISEASES [J].
DUCHIN, KL ;
MCKINSTRY, DN ;
COHEN, AI ;
MIGDALOF, BH .
CLINICAL PHARMACOKINETICS, 1988, 14 (04) :241-259
[10]  
ELBERT T, 1991, INTEROCEPTION CARDIO, P75